openPR Logo
Press release

Forecast Research Reports Offers Key Insights Sulfonamides Market

08-20-2021 11:27 AM CET | Industry, Real Estate & Construction

Press release from: Transparency Market Research

Sulfonamides Market

Sulfonamides Market

Sulfonamides Market: Outlook

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don't surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal's body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.

Request For Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67355

Sulfonamides are bacteriostatic agents that aids to fight with the multiple chronic diseases in human.

Increasing Research & Development in pharmaceutical companies also help to improved different types of sulfonamides with improved in the therapeutic activity is a major driver of the sulfonamides global market. Other than this bacteriostatic agents function of sulfonamides also help to fuel the global sulfonamides market growth in the current and the forecast period. Day by day increasing number of chronic diseases such as arthritis, asthma, diabetes, etc all over the world and the significant availability of different types of sulfonamide drug which can be produced at an affordable price to grasp the growing demand, are the major factors which contribute to the growth of the global sulfonamides market. Hence, along with the strong characteristic as bacteriostatic agents sulfonamides also cause some side effect to the people such as lethargy, nausea, diarrhea, headache, anorexia, serious skin rashes and dizziness.

Buy Now : https://www.transparencymarketresearch.com/checkout.php?rep_id=67355<ype=S

Global Sulfonamides market: Key Players

Some of the major manufacturers and suppliers operating in the global sulfonamides market are Novartis AG, Sanofi S.A., Roche Holding AG, Mylan N.V., King Pharmaceuticals, Inc., Stiefel Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Abbott Laboratories, GlaxoSmithKline plc, Par Pharmaceutical, Inc. other than this there are some more players in sulfonamides global market. Hence many new players are also interested in this market to capture the growing demand of sulfonamides as a bacteriostatic.

Explore Transparency Market Research’s award-winning coverage of the global Industry:
https://www.prnewswire.com/news-releases/increasing-preference-towards-high-protein-diet-that-is-ready-to-go-is-fueling-growth-of-global-meat-extract-market-valuation-to-reach-us-2-5-bn-by-2029--transparency-market-research-301003674.html

Opportunities for Market Participants in the Sulfonamides market:

Sulfonamide as an bacteriostatic agent help to fight with the number of chronic diseases in the human body, and according to the World Health Organization, it is found that by the year 2020 chronic disease is expected to rise by 57% all over the world. This factor helps to generate more opportunities for the current and new players of sulfonamides market. Along with this rapid increasing medical tourism industry and health care spending aid to generate more opportunity for the sulfonamides market players to serve the larger market segment. In the current time, there is very less number of sulfonamides manufacturers who can meet the rising demand of pharmaceutical industry for sulfonamides, this less number of manufacturers showcase the opportunity for the new players to enter into the sulfonamides global market and help to meet the demand from the consumers. Sulfonamides market is a growing market due to its multiple health effects to the consumer who is suffering from chronic diseases that shows the lucrative growth in the forecasted period too.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Forecast Research Reports Offers Key Insights Sulfonamides Market here

News-ID: 2361608 • Views:

More Releases from Transparency Market Research

Medical Education Market to Surpass US$ 247.0 Bn by 2035, Fueled by Digital Transformation and AI Integration - Transparency Market Research
Medical Education Market to Surpass US$ 247.0 Bn by 2035, Fueled by Digital Tran …
The global medical education market was valued at US$ 83.2 Bn in 2024. It is projected to grow at a CAGR of 10.2% from 2025 to 2035, reaching over US$ 247.0 Bn by the end of 2035, according to a new report by Transparency Market Research. The expansion is attributed to rising demand for healthcare professionals, technological advances in training delivery, and a growing number of public-private medical education partnerships. Get
Regulatory Affairs Outsourcing Market to Exceed US$ 22.3 Bn by 2035, Driven by Increasing Regulatory Complexity and Global Expansion Needs - Transparency Market Research
Regulatory Affairs Outsourcing Market to Exceed US$ 22.3 Bn by 2035, Driven by I …
The global regulatory affairs outsourcing market was valued at US$ 7.4 Bn in 2024. It is projected to grow at a CAGR of 10.6% from 2025 to 2035, reaching over US$ 22.3 Bn by the end of 2035, according to a new report by Transparency Market Research. Heightened global regulatory scrutiny and rising demand for local representation across emerging markets are fueling outsourcing trends across pharmaceutical, biotechnology, and medical device
Brain Computer Interface Market to Surpass US$ 4.3 Bn by 2035, Fueled by Advances in Neurotechnology and Rising Neurological Disorders - Transparency Market Research
Brain Computer Interface Market to Surpass US$ 4.3 Bn by 2035, Fueled by Advance …
The global brain computer interface market was valued at US$ 1.3 Bn in 2024. The industry is projected to expand at a CAGR of 11.2% from 2025 to 2035 and surpass US$ 4.3 Bn by the end of 2035, according to a new study published by Transparency Market Research. Increasing prevalence of neurological disorders, coupled with innovations in non-invasive and implantable BCI technologies, are driving market expansion. Get Sample PDF Brochure
Ghana Active Wound Care Market Forecast 2035: Rising Chronic Wound Cases and Healthcare Infrastructure Improvements Fuel Market Demand | Transparency Market Research, Inc
Ghana Active Wound Care Market Forecast 2035: Rising Chronic Wound Cases and Hea …
The Ghana active wound care market is poised for steady growth, projected to expand from a valuation of USD 663.8 thousand in 2024 to USD 863.0 thousand by 2035, at a compound annual growth rate (CAGR) of 2.2% between 2025 and 2035. The market is witnessing transformation driven by the rise in chronic wound incidences, a shift toward advanced wound management technologies, and significant developments in Ghana's healthcare infrastructure. Market Overview:

All 5 Releases


More Releases for Sulfonamide

Sulfonamide Market Projected to Witness a Double-Digit CAGR During 2030
Sulfonamide Market: Introduction Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food
Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and …
Sulfonamide Market: Introduction Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food
Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Highlighted k …
Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not synthesize folic acid, but a
Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market | Analysis & …
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Trends …
Sulfonamide are antibiotics which clinical use since years. These drugs are bacteriostatic in nature and are utilized in the treatment of acute, infectious and various other bacterial infections. The drivers for the systemic antibiotic sulfonamide marketwhich pushes volume sale of the drug includes the availability of a large number of generics at affordable prices, increasing the prevalence of various infectious diseases and the worldwide rise in elderly population. For the
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Indust …
Sulfonamide are antibiotics which clinical use since years. These drugs are bacteriostatic in nature and are utilized in the treatment of acute, infectious and various other bacterial infections. The drivers for the systemic antibiotic sulfonamide marketwhich pushes volume sale of the drug includes the availability of a large number of generics at affordable prices, increasing the prevalence of various infectious diseases and the worldwide rise in elderly population. For the